Bovine Lactoferrin Market
Growth Factors of Bovine Lactoferrin Market
The bovine lactoferrin market size was valued at USD 667.3 billion in 2023, and the market is now projected to grow from USD 676.2 billion in 2024 to USD 922.2 billion by 2032, exhibiting a CAGR of 4.0% during the forecast period of 2024-2032.
The outbreak of COVID-19 led to a slump in the bovine lactoferrin market growth accompanied by average sale prices reduced by excessive capacity additions. However, gross volumes of bovine lactoferrin shot up in 2021 compared to 2020. This was facilitated by the fact that many players were producing and availing more products locally and internationally in the market.
The affordability of agricultural manufacturing procedures and the constant study of bovine lactoferrin's ability in cancer treatments contribute to the bovine lactoferrin market share. A fraction of success with regards to lactoferrin was shown in a 2021 study especially when it came to respiratory infections. Increased demand from the infant formula market stemming from the decline in breastfeeding rates in the Asia Pacific contributes to this market. Ongoing research on new indications and technological advancement is probably to improve product penetration in the market.
Further, China’s campaign to promote indigenously made products gradually strayed customers away from foreign brands including upgraded infant formulas in compliance with the new GB standards. Apart from its application in infant formulations, lactoferrin is applied in dietary supplements, foods and drugs. Prospective demand is being spurred by rising interest in natural supplements and a higher number of clinical trials in pharmaceuticals. New product launches in the digestion and immunity categories, alongside investment into research and development also drive the market.
Comprehensive Analysis of Bovine Lactoferrin Market
The bovine lactoferrin market and healthcare industry is growing exponentially and this growth can be attributed to the market segmentation. This market expansion offers essentially a comprehensive regional analysis as per the current supply and demand dynamics of the pharmaceutical sector. These segmentations are systematically separated by product and by application. The product includes, spray-dried and freeze-dried. The applications include, infant formula, pharmaceuticals, dietary supplements, food and others.
The Asia Pacific market was valued at USD 376.7 million in 2023 due to an increasing need for baby formula and nutritional supplements. The current trend of low breastfeeding rates has led to higher demand for infant formula hence leading to the implementation of lactoferrin as an additional boost to nutrition. The increasing consumption of lactoferrin as a complementary food used with breast milk is further boosting the market’s growth in the region.
The market of bovine lactoferrin and the healthcare sector is rapidly growing due to the segmentation of markets. These players include, MILEI GmbH (Germany), Bega Cheese Limited (Australia), Fonterra Co-operative Group Limited (New Zealand), FrieslandCampina (Netherlands), Beston Global Food Company Ltd (Australia), SAVENCIA SA (France), Saputo Dairy Australia Pty Ltd. (Australia), Noumi Limited (Australia), Synlait Ltd. (New Zealand), Glanbia PLC (Ireland) and Ingredia (France). These market players provide a level-playing competitive landscape.
In February 2023, Morinaga Milk Industry Co., Ltd. purchased shares of Le May Production, a company involved in the import and export of infant and toddler milk, aiming to enhance the nutritional infrastructure in Asia.
Segmentation Table
Global Bovine Lactoferrin Market Scope
Study Period 2019-2032
Base Year 2023
Forecast Period 2024-2032
Growth Rate CAGR of 4.0% from 2024 to 2032
Historical Period 2019-2022
Unit Value (USD Billion)
Segmentation By Product, Application, and Region
By Product
Freeze-driedBy Application
Infant Formula- Dietary Supplements
- Pharmaceiticals
- Food
- Others
By Region
North America (By Product, Application, and Country)- U.S.
- Canada
- Europe (By Product, Application, and Country/Sub Region)
- U.K.
- Germany
- France
- Italy
- Spain
- Scandinavia
- Rest of Europe
- Asia Pacific (By Product, Application, and Country/Sub Region)
- Japan
- China
- India
- Australia
- Southeast Asia
- Rest of Asia Pacific
- Latin America (By Product, Application, and Country/Sub Region)
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa (By Product, Application, and Country/Sub Region)
- South Africa
- GCC
- Rest of the Middle East & Africa